Activity of the Oral Neuraminidase Inhibitor A-322278 against the Oseltamivir-Resistant H274Y (A/H1N1) Influenza Virus Mutant in Mice

被引:15
|
作者
Baz, Mariana
Abed, Yacine
Nehme, Benjamin
Boivin, Guy [1 ]
机构
[1] CHUL, CHUQ, Res Ctr Infect Dis, Ste Foy, PQ G1V 4G2, Canada
关键词
A-315675; INFECTION;
D O I
10.1128/AAC.01276-08
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The new oral neuraminidase (NA) inhibitor A-322278 was evaluated in mice infected with influenza A/H1N1 wild-type virus or the oseltamivir-resistant (H274Y mutant) virus. A-322278 decreased mortality rates and lung virus titers significantly more than oseltamivir in mice infected with the NA H274Y mutant when therapy was started 4 h before or even 48 h after infection.
引用
收藏
页码:791 / 793
页数:3
相关论文
共 50 条
  • [21] Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice
    Easterbrook, Judith D.
    Schwartzman, Louis M.
    Gao, Jin
    Kash, John C.
    Morens, David M.
    Couzens, Laura
    Wan, Hongquan
    Eichelberger, Maryna C.
    Taubenberger, Jeffery K.
    VIROLOGY, 2012, 432 (01) : 39 - 44
  • [22] New Orf Virus (Parapoxvirus) Recombinant Expressing H5 Hemagglutinin Protects Mice against H5N1 and H1N1 Influenza A Virus
    Rohde, Joerg
    Amann, Ralf
    Rziha, Hanns-Joachim
    PLOS ONE, 2013, 8 (12):
  • [23] Prevalence of Influenza A(H1N1)pdm09 Virus Resistant to Oseltamivir in Shiraz, Iran, During 2012-2013
    Khodadad, Nastaran
    Moattari, Afagh
    Abadi, Mahmoud Shamsi Shahr
    Kadivar, Mohammad Rahim
    Sarvari, Jamal
    Tavakoli, Forough
    Pirbonyeh, Neda
    Emami, Amir
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2015, 8 (08)
  • [24] In Vivo Therapeutic Protection against Influenza A (H1N1) Oseltamivir-Sensitive and Resistant Viruses by the Iminosugar UV-4
    Stavale, Eric J.
    Hong Vu
    Sampath, Aruna
    Ramstedt, Urban
    Warfield, Kelly L.
    PLOS ONE, 2015, 10 (03):
  • [25] The I222V Neuraminidase Mutation Has a Compensatory Role in Replication of an Oseltamivir-Resistant Influenza Virus A/H3N2 E119V Mutant
    Simon, Philippe
    Holder, Benjamin P.
    Bouhy, Xavier
    Abed, Yacine
    Beauchemin, Catherine A. A.
    Boivin, Guy
    JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (02) : 715 - 717
  • [26] The Neuraminidase Inhibitor Oseltamivir Is Effective Against A/Anhui/1/2013 (H7N9) Influenza Virus in a Mouse Model of Acute Respiratory Distress Syndrome
    Baranovich, Tatiana
    Burnham, Andrew J.
    Marathe, Bindumadhav M.
    Armstrong, Jianling
    Guan, Yi
    Shu, Yuelong
    Peiris, Joseph Malik Sriyal
    Webby, Richard J.
    Webster, Robert G.
    Govorkova, Elena A.
    JOURNAL OF INFECTIOUS DISEASES, 2014, 209 (09) : 1343 - 1353
  • [27] Efficacy of inactivated swine influenza virus vaccines against the 2009 A/H1N1 influenza virus in pigs
    Vincent, Amy L.
    Ciacci-Zanella, Janice R.
    Lorusso, Alessio
    Gauger, Philip C.
    Zanella, Eraldo L.
    Kehrli, Marcus E., Jr.
    Janke, Bruce H.
    Lager, Kelly M.
    VACCINE, 2010, 28 (15) : 2782 - 2787
  • [28] Pandemic 2009 H1N1 Influenza Virus Is Resistant to the Antiviral Activity of Several Interferon Alpha Subtypes
    Scagnolari, Carolina
    Trombetti, Simona
    Solda, Annalisa
    Selvaggi, Carla
    Monteleone, Katia
    Spano, Lucia
    Pierangeli, Alessandra
    Clementi, Massimo
    Turriziani, Ombretta
    Antonelli, Guido
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2011, 31 (06) : 475 - 479
  • [29] Combination of ribavirin and reduning protects mice against severe pneumonia induced by H1N1 influenza a virus
    Ma Yuexia
    Zhang Wei
    Zhao Zhongpeng
    Li Min
    Liu Jian
    Wang Yuguang
    JOURNAL OF TRADITIONAL CHINESE MEDICINE, 2016, 36 (02) : 181 - 186
  • [30] Pulmonary immune responses to 2009 pandemic influenza A (H1N1) virus in mice
    Lv, Jin
    Wang, Dan
    Hua, Yan-Hong
    Pei, Shi-Jia
    Wang, Jin
    Hu, Wen-Wei
    Wang, Xi-Liang
    Jia, Na
    Jiang, Qi-Sheng
    BMC INFECTIOUS DISEASES, 2014, 14